LLY

Eli Lilly and Company

Healthcare·Mega Cap

Eli Lilly is a pharmaceutical giant leading the GLP-1 drug revolution with Mounjaro and Zepbound. LLY has been one of the strongest momentum stocks in the market, driven by blockbuster drug sales projections and institutional conviction.

LLY is a GLP-1 drug juggernaut where Mounjaro and Zepbound sales projections, supply expansion updates, and competitive pipeline data drive the biggest moves. The page should explain why LLY trades like a growth stock and how to frame risk around clinical and regulatory catalysts.

Momentum BreakoutEarnings PlayMulti-FactorOptions Flow
Research hub

Healthcare can stay quiet until pipeline or earnings headlines break the range.

Healthcare names may look slow until a catalyst changes the chart. Earnings, pipeline updates, and defensive rotation can all matter, so a clean checklist around support, trend, and downside risk helps keep the setup grounded.

MomentumRelative StrengthVWAP (Volume Weighted Average Price)Earnings Per Share (EPS)

Quick checklist before you trade

Start FreeOpen AppExplore Signals

Signal Performance — LLY (Last 90 Days)

Total Signals

7

Win Rate

33.3%

1W / 2L

Avg P&L

+0.1%

Avg Confidence

48%

Best: +4%

Signal TypeSignalsWin RateAvg P&L
Exit Alert40%-0.4%
Momentum Alert350%+0.7%

Recent AI Signals for LLY

BearishExit Alertintraday
Confidence48.8%
R/R0×
Stop$0
Aug 20, 2026
Entry
$1255.48–$1268.1
Stop
$0
Target
$0

The original bullish momentum thesis is broken. Price has fallen significantly below the entry zone and is approaching the stop loss. Key technical indicators like the Bollinger Band position and volume trend suggest a loss of upward conviction and potential reversal.

BullishMomentum Alertintraday
-2%
Confidence44.4%
R/R2×
Stop$1254.73
Aug 20, 2026
Entry
$1276.5–$1284.18
Stop
$1254.73
Target
$1331.55

LLY is exhibiting strong intraday bullish momentum, evidenced by a significant price increase coupled with above-average volume. This suggests conviction behind the move, potentially indicating further upside if this trend continues. Traders should monitor for continued volume support and price consolidation above $1280.34 to confirm the strength of this momentum signal.

BearishExit Alertintraday
Confidence51.2%
R/R0×
Stop$0
Aug 7, 2026
Entry
$1183.28–$1195.17
Stop
$0
Target
$0

The original bullish momentum thesis is weakening. Price has failed to make significant progress towards the target and is now trading below the 20-day SMA. Volume is significantly lower than average, indicating a lack of conviction behind any potential upward move, and the RSI is trending downwards.

BearishExit Alertintraday
-1.8%
Confidence45.9%
R/R0×
Stop$0
Aug 6, 2026
Entry
$1164.01–$1175.71
Stop
$0
Target
$0

The original bullish momentum thesis is weakening significantly. Price has moved below the 20-day SMA and is approaching the stop loss. While volume remains elevated, the OBV trend indicates distribution, suggesting selling pressure is increasing despite intraday gains.

BullishMomentum Alertintraday
Confidence55.2%
R/R2×
Stop$1164.36
Aug 6, 2026
Entry
$1184.55–$1191.68
Stop
$1164.36
Target
$1235.64

LLY is exhibiting strong intraday bullish momentum, evidenced by a significant +6.5% price surge on 2.4x average volume. This indicates substantial buying pressure and conviction from market participants, suggesting the upward trend may continue in the short term. Traders should monitor for potential continuation patterns or resistance levels around the current price of $1188.12.

BearishExit Alertintraday
Confidence45.7%
R/R0×
Stop$0
Aug 5, 2026
Entry
$1154.82–$1166.42
Stop
$0
Target
$0

The price has fallen back into the entry zone and is now trading below the 20-day SMA, indicating a loss of upward momentum. The OBV trend is showing distribution, and the ROC indicators are negative, suggesting selling pressure is increasing and the original bullish thesis is weakening.

BullishMomentum Alertintraday
+4%
Confidence44.9%
R/R2×
Stop$1140.86
Aug 5, 2026
Entry
$1160.65–$1167.63
Stop
$1140.86
Target
$1210.71

LLY is exhibiting strong intraday upward momentum, evidenced by a significant price increase of 4.3% on 1.5 times average volume. This suggests increasing buying pressure and conviction from market participants. Traders should monitor for continued volume expansion and price consolidation above the current level for confirmation of sustained momentum.

Why LLY deserves a deeper read

Why LLY trades like the best growth stock in the market

LLY has been one of the strongest momentum stocks in the market because the GLP-1 drug market is projected to reach hundreds of billions in annual revenue, and Lilly has the leading products with Mounjaro and Zepbound. Institutional conviction is high, and the stock frequently makes new all-time highs.

The page is most useful when it explains that LLY is not a typical pharma stock. It trades with the momentum and conviction characteristics of a mega-cap tech name, which means the same trend-following and breakout frameworks apply.

  • GLP-1 prescription and sales data are the primary drivers — watch quarterly trends.
  • Supply expansion updates can move the stock as much as earnings because they uncap revenue potential.
  • Compare LLY against SPY and QQQ to see whether it is leading or following the broader market.
MomentumRelative strengthTrend following

How to trade LLY around earnings and clinical data

LLY earnings are driven by GLP-1 sales trajectory and forward guidance on supply capacity. The stock can move 5-10% on these reports. Clinical trial readouts for new indications or next-generation compounds add another layer of catalyst risk.

The best earnings setups on LLY tend to be continuation trades. If the stock is already trending higher into earnings and the numbers confirm the thesis, the post-earnings breakout often extends. If the stock is stretched, even a beat may produce a sell-the-news reaction.

  • GLP-1 sales growth and guidance raises are the numbers that matter most.
  • Clinical readouts for obesity, cardiovascular, and metabolic indications create binary risk events.
  • Use VWAP to anchor entries after the earnings gap settles.
Implied volatilityVWAP

Managing risk on a stock with a premium valuation

LLY trades at a premium valuation that prices in years of GLP-1 growth. That means any negative surprise — a competitive drug approval, supply shortage, or regulatory headwind — can produce a 10%+ decline because the expectation bar is so high.

The page should help traders size for this downside risk. LLY rewards trend followers, but the trend can reverse sharply when the narrative shifts. Defined stops and realistic position sizes are essential.

  • Premium valuations mean the downside risk on a negative surprise is larger than average.
  • Size positions for the possibility of a 10%+ decline on competitive or regulatory news.
  • Use trailing stops to protect gains on the trend rather than trying to pick the top.
Stop lossPosition sizingRisk management

Best comparison tickers for LLY

These peer pages help you see whether the move is stock-specific or part of a broader leadership cluster. Trading pages that point to the right comparison set tend to keep visitors moving through the site instead of bouncing back to search results.

SPYIndex ETF

SPDR S&P 500 ETF

SPY is a clean market-regime read: breadth, volatility, and macro news often matter more than any single company headline. The page should make it obvious how SPY fits into the broader Tradewink workflow, because it tells traders when single-name setups deserve attention and when the market itself is sending a caution signal.

QQQIndex ETF

Invesco QQQ Trust

QQQ often reflects Nasdaq leadership, rate sensitivity, and momentum concentration, making it useful for regime-aware trade selection. A strong stock page should explain how QQQ differs from SPY, why it matters for growth-stock leadership, and how traders can use it to judge whether tech is actually leading.

COSTLarge Cap

Costco Wholesale Corp.

COST is a defensive growth stock where monthly same-store sales, membership renewal rates, and consumer spending trends drive steady momentum patterns. The page should explain how COST differs from cyclical retailers and why it holds up better in risk-off environments.

AVGOMega Cap

Broadcom Inc.

AVGO is an AI infrastructure bellwether with custom ASIC chip design and networking exposure that makes it the second-most-important AI semiconductor stock after NVDA. The page should explain how AVGO's custom silicon business differentiates it from GPU-focused NVDA.

Strategy pages worth comparing against LLY

These links turn ticker-intent traffic into a practical decision path. Instead of treating the stock as a one-off headline, compare the live chart with a named strategy and decide whether the setup is closer to a breakout, a bounce, or an event-driven move.

Momentum Breakout Strategy

Buy stocks breaking above key resistance levels on surging volume.

Trend Following Strategy

Ride established trends using moving average crossovers and trailing stops.

Opening Range Breakout (ORB) Strategy

Trade the breakout of the first 15-30 minutes of trading for directional bias.

Learn before you decide on LLY

The strongest organic pages do more than list data. They help readers connect the chart to the language of trading, risk, and execution. These guides do that in a way that stays practical and non-promissory.

Risk Management for Traders

Learn why stops, sizing, and position heat matter before any entry.

What Is VWAP?

Learn how the session benchmark works before you try to trade around it.

Paper Trading Guide

Practice entries, stops, and sizing with live market context before risking capital.

ATR Indicator Guide

Use volatility to set stops and position size instead of guessing at noise.

Fear and Greed Index Explained

Use sentiment as a macro filter when you decide whether the tape is stretched.

What Is a Market Regime?

Learn when trend, chop, and volatility shifts change which setups have an edge.

Glossary terms that give this stock context

Open these first if you are comparing the live page with a chart or a trading setup. They explain the mechanics behind the levels and signals you see here.

Momentum

The rate of acceleration of a stock's price — a measure of how quickly and strongly the price is moving in a given direction.

Relative Strength

A measure of how a stock's price performance compares to a benchmark — typically the S&P 500 — over a defined period. Stocks with high relative strength are outperforming the market; stocks with low relative strength are underperforming. Not to be confused with the RSI (Relative Strength Index), which measures a stock's momentum against its own recent price history.

VWAP (Volume Weighted Average Price)

The average price of a stock weighted by volume throughout the trading day, acting as a benchmark for institutional execution quality.

Earnings Per Share (EPS)

A company's net profit divided by its number of outstanding shares — the most widely used measure of corporate profitability.

Keep LLY on your watchlist with a free account

Create an account to save the ticker, compare it with nearby names, and receive alerts when Tradewink finds a setup that matches your risk rules. The page stays readable without sign-up, but the watchlist workflow is what makes the research reusable.

Get started freeOpen AppView more stocks

How Tradewink Reviews LLY

Signal monitoring

When up-to-date market data is available, the system checks for breakout setups, volume changes, and momentum shifts.

Market context

Options activity, market data, and other available context help explain why a setup may warrant more research.

Setup assessment

Technicals, fundamentals, flow, and sentiment are presented as context to inspect—not a prediction or trade instruction.

Available Signal Types for LLY

Momentum Breakout Signals

AI flags price breaks above defined resistance when volume expands. Alerts include the level, supporting data, and risk context for review.

Earnings Play Signals

AI reviews earnings dates, implied volatility, price trends, and recent company updates to surface educational pre- and post-earnings setups.

AI Multi-Factor Analysis

AI combines technical, fundamental, flow, and sentiment inputs into a composite score with supporting evidence and stated risks.

Options Flow Signals

AI monitors unusual options volume, sweeps, blocks, and related price action to surface activity that may warrant further review.

Explore More Stocks

These peer pages help keep the internal link graph strong and give you a faster way to compare names in the same market bucket.

NVOHealthcareHIMSHealthcareMRKHealthcareISRGHealthcareUNHHealthcareMRNAHealthcare
View All Stocks

Tradewink is not a registered investment adviser, broker-dealer, or financial planner. All data, signals, and analytics on this page are for informational purposes only and do not constitute investment advice, financial advice, or a recommendation to buy or sell any security.

Past performance does not guarantee future results. Trading involves substantial risk of loss, including the possibility of losing more than your initial investment. You are solely responsible for your own trading decisions.